BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36787364)

  • 1. Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer's disease.
    Fairley LH; Lai KO; Wong JH; Chong WJ; Vincent AS; D'Agostino G; Wu X; Naik RR; Jayaraman A; Langley SR; Ruedl C; Barron AM
    Proc Natl Acad Sci U S A; 2023 Feb; 120(8):e2209177120. PubMed ID: 36787364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance.
    Leng L; Yuan Z; Pan R; Su X; Wang H; Xue J; Zhuang K; Gao J; Chen Z; Lin H; Xie W; Li H; Chen Z; Ren K; Zhang X; Wang W; Jin ZB; Wu S; Wang X; Yuan Z; Xu H; Chow HM; Zhang J
    Nat Metab; 2022 Oct; 4(10):1287-1305. PubMed ID: 36203054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Honokiol Restores Microglial Phagocytosis by Reversing Metabolic Reprogramming.
    Li W; Wang S; Zhang H; Li B; Xu L; Li Y; Kong C; Jiao H; Wang Y; Pang Y; Qin W; Jia L; Jia J
    J Alzheimers Dis; 2021; 82(4):1475-1485. PubMed ID: 34151796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of high molecular weight kininogen in the brains of Alzheimer's disease patients may affect microglial function by altering phagocytosis and lysosomal cathepsin activity.
    Zamolodchikov D; Duffield M; Macdonald LE; Alessandri-Haber N
    Alzheimers Dement; 2022 Oct; 18(10):1919-1929. PubMed ID: 34978145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSPO deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis.
    Zhang H; Wang H; Gao F; Yang J; Xu Y; Fu Y; Cai M; Zhang X; Yang Q; Tong K; Hu Y; Chen H; Ma C; He W; Zhang J
    Neurobiol Aging; 2021 Oct; 106():292-303. PubMed ID: 34340010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TLR2 antibody triggers oxidative phosphorylation in microglia and increases phagocytosis of β-amyloid.
    Rubio-Araiz A; Finucane OM; Keogh S; Lynch MA
    J Neuroinflammation; 2018 Aug; 15(1):247. PubMed ID: 30170611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognition-enhancing effect of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in the 5 × FAD transgenic mouse model of Alzheimer's pathology.
    Dai W; Yao RM; Mi TY; Zhang LM; Wu HL; Cheng JB; Li YF
    J Psychopharmacol; 2022 Oct; 36(10):1176-1187. PubMed ID: 36069168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia in Alzheimer's Disease: A Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis.
    Sumsuzzman DM; Uddin MS; Kabir MT; Hasana S; Perveen A; Alanazi IS; Albadrani GM; Abdel-Daim MM; Ashraf GM
    Mediators Inflamm; 2022; 2022():6052932. PubMed ID: 35693110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics.
    Lepiarz-Raba I; Gbadamosi I; Florea R; Paolicelli RC; Jawaid A
    Transl Neurodegener; 2023 Oct; 12(1):48. PubMed ID: 37908010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease.
    Ghosh S; Geahlen RL
    EBioMedicine; 2015 Nov; 2(11):1785-98. PubMed ID: 26870803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer's disease-like mice.
    Li Q; Peng J; Luo Y; Zhou J; Li T; Cao L; Peng S; Zuo Z; Wang Z
    J Neuroinflammation; 2022 Jun; 19(1):145. PubMed ID: 35701825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer's Disease.
    Fairley LH; Wong JH; Barron AM
    Front Immunol; 2021; 12():624538. PubMed ID: 33717134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ.
    Jo KW; Lee D; Cha DG; Oh E; Choi YH; Kim S; Park ES; Kim JK; Kim KT
    Alzheimers Res Ther; 2022 Oct; 14(1):158. PubMed ID: 36271414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice.
    McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA
    Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium rutin ameliorates Alzheimer's disease-like pathology by enhancing microglial amyloid-β clearance.
    Pan RY; Ma J; Kong XX; Wang XF; Li SS; Qi XL; Yan YH; Cheng J; Liu Q; Jin W; Tan CH; Yuan Z
    Sci Adv; 2019 Feb; 5(2):eaau6328. PubMed ID: 30820451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
    Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
    J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
    Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
    Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease.
    Baik SH; Kang S; Lee W; Choi H; Chung S; Kim JI; Mook-Jung I
    Cell Metab; 2019 Sep; 30(3):493-507.e6. PubMed ID: 31257151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
    Heneka MT; Nadrigny F; Regen T; Martinez-Hernandez A; Dumitrescu-Ozimek L; Terwel D; Jardanhazi-Kurutz D; Walter J; Kirchhoff F; Hanisch UK; Kummer MP
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6058-63. PubMed ID: 20231476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.